|
 The U.S. Centers for Disease Control and Prevention will hold an
advisory meeting on Wednesday to review the cases.
All the six recipients were women between the ages of 18 and 48. One
woman died and a second in Nebraska has been hospitalized in
critical condition, the New York Times reported, citing officials.
(https://nyti.ms/3g70oLK)
The CDC and the U.S. Food and Drug Administration said in a joint
statement that the adverse events appear to be extremely rare right
now.
As of April 12, more than 6.8 million doses of the Johnson & Johnson
vaccine have been administered in the United States.
[to top of second column] |
 The company's shares were down
3% before the opening bell.
The move from the U.S. regulators comes less
than a week after Europe's drugs regulator said
it was reviewing rare blood clots in four people
in the United States who received the shot.
(Reporting by Manas Mishra in Bengaluru; Editing
by Maju Samuel and Sriraj Kalluvila)
[© 2021 Thomson Reuters. All rights
reserved.] Copyright 2021 Reuters. All rights reserved. This material may not be published,
broadcast, rewritten or redistributed.
Thompson Reuters is solely responsible for this content |
